Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
SHANGHAI, China — Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market, where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic
Read More